Amid Delivery Tech Dispute, Alnylam Forges Collaboration with Precision NanoSystems

The companies expect Precision's technology to enable RNAi drug delivery to tissues beyond the liver. The deal is the latest in a number of delivery agreements that have been struck in the last year.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.